Table of Contents

Global Vasopressin Market Growth 2019-2024

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Vasopressin Consumption 2014-2024
  • 2.1.2 Vasopressin Consumption CAGR by Region
• 2.2 Vasopressin Segment by Type
  • 2.2.1 Intravenous Injection
  • 2.2.2 Intramuscular Injection
  • 2.2.3 Subcutaneous Injection
• 2.3 Vasopressin Consumption by Type
  • 2.3.1 Global Vasopressin Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Vasopressin Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Vasopressin Sale Price by Type (2014-2019)
• 2.4 Vasopressin Segment by Application
  • 2.4.1 Anti-Diuretic Hormone Deficiency
  • 2.4.2 Vasodilatory Shock
  • 2.4.3 Gastrointestinal Bleeding
  • 2.4.4 Ventricular Tachycardia & Fibrillation
• 2.5 Vasopressin Consumption by Application
  • 2.5.1 Global Vasopressin Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Vasopressin Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Vasopressin Sale Price by Application (2014-2019)

3 Global Vasopressin by Manufacturers

• 3.1 Global Vasopressin Sales Market Share by Manufacturers
  • 3.1.1 Global Vasopressin Sales by Manufacturers (2017-2019)
  • 3.1.2 Global Vasopressin Sales Market Share by Manufacturers (2017-2019)
• 3.2 Global Vasopressin Revenue Market Share by Manufacturers
  • 3.2.1 Global Vasopressin Revenue by Manufacturers (2017-2019)
  • 3.2.2 Global Vasopressin Revenue Market Share by Manufacturers (2017-2019)
• 3.3 Global Vasopressin Sale Price by Manufacturers
• 3.4 Global Vasopressin Manufacturing Base Distribution, Sales Area, Product Types by Manufacturers
  • 3.4.1 Global Vasopressin Manufacturing Base Distribution and Sales Area by Manufacturers
  • 3.4.2 Players Vasopressin Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Vasopressin by Regions

• 4.1 Vasopressin by Regions
  • 4.1.1 Global Vasopressin Consumption by Regions
  • 4.1.2 Global Vasopressin Value by Regions
• 4.2 Americas Vasopressin Consumption Growth
• 4.3 APAC Vasopressin Consumption Growth
• 4.4 Europe Vasopressin Consumption Growth
• 4.5 Middle East & Africa Vasopressin Consumption Growth

5 Americas

• 5.1 Americas Vasopressin Consumption by Countries
  • 5.1.1 Americas Vasopressin Consumption by Countries (2014-2019)
  • 5.1.2 Americas Vasopressin Value by Countries (2014-2019)
• 5.2 Americas Vasopressin Consumption by Type
• 5.3 Americas Vasopressin Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Vasopressin Consumption by Countries
  • 6.1.1 APAC Vasopressin Consumption by Countries (2014-2019)
  • 6.1.2 APAC Vasopressin Value by Countries (2014-2019)
• 6.2 APAC Vasopressin Consumption by Type
• 6.3 APAC Vasopressin Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Vasopressin by Countries
  • 7.1.1 Europe Vasopressin Consumption by Countries (2014-2019)
  • 7.1.2 Europe Vasopressin Value by Countries (2014-2019)
• 7.2 Europe Vasopressin Consumption by Type
• 7.3 Europe Vasopressin Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Vasopressin by Countries
  • 8.1.1 Middle East & Africa Vasopressin Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Vasopressin Value by Countries (2014-2019)
• 8.2 Middle East & Africa Vasopressin Consumption by Type
• 8.3 Middle East & Africa Vasopressin Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Vasopressin Distributors
• 10.3 Vasopressin Customer

11 Global Vasopressin Market Forecast

• 11.1 Global Vasopressin Consumption Forecast (2019-2024)
• 11.2 Global Vasopressin Forecast by Regions
  • 11.2.1 Global Vasopressin Forecast by Regions (2019-2024)
  • 11.2.2 Global Vasopressin Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Vasopressin Forecast by Type
• 11.8 Global Vasopressin Forecast by Application

12 Key Players Analysis

• 12.1 Par Pharmaceutical
  • 12.1.1 Company Details
  • 12.1.2 Vasopressin Product Offered
  • 12.1.3 Par Pharmaceutical Vasopressin Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Par Pharmaceutical News
• 12.2 Pfizer
  • 12.2.1 Company Details
  • 12.2.2 Vasopressin Product Offered
  • 12.2.3 Pfizer Vasopressin Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Pfizer News
• 12.3 Novartis
  • 12.3.1 Company Details
  • 12.3.2 Vasopressin Product Offered
  • 12.3.3 Novartis Vasopressin Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Novartis News
• 12.4 Ferring Pharmaceuticals
  • 12.4.1 Company Details
  • 12.4.2 Vasopressin Product Offered
  • 12.4.3 Ferring Pharmaceuticals Vasopressin Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Ferring Pharmaceuticals News
• 12.5 Fresenius Kabi Canada
  • 12.5.1 Company Details
  • 12.5.2 Vasopressin Product Offered
  • 12.5.3 Fresenius Kabi Canada Vasopressin Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Fresenius Kabi Canada News
• 12.6 Astellas Pharma
  • 12.6.1 Company Details
  • 12.6.2 Vasopressin Product Offered
  • 12.6.3 Astellas Pharma Vasopressin Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Astellas Pharma News
• 12.7 Shanghai Soho-Yiming Pharmaceuticals
  • 12.7.1 Company Details
  • 12.7.2 Vasopressin Product Offered
  • 12.7.3 Shanghai Soho-Yiming Pharmaceuticals Vasopressin Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 Shanghai Soho-Yiming Pharmaceuticals News

...

13 Research Findings and Conclusion

According to this study, over the next five years the Vasopressin market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Vasopressin business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Vasopressin market by product type, application, key manufacturers and key regions and countries.

This study considers the Vasopressin value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Intravenous Injection
Intramuscular Injection
Subcutaneous Injection

Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Anti-Diuretic Hormone Deficiency
Vasodilatory Shock
Gastrointestinal Bleeding
Ventricular Tachycardia & Fibrillation

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Par Pharmaceutical
Pfizer
Novartis
Ferring Pharmaceuticals
Fresenius Kabi Canada
Astellas Pharma
Shanghai Soho-Yiming Pharmaceuticals
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Vasopressin consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Vasopressin market by identifying its various subsegments.
Focuses on the key global Vasopressin manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Vasopressin with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Vasopressin submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.